An update on methods for detection of prognostic and predictive biomarkers in melanoma.

Adeuyan, Oluwaseyi; Gordon, Emily R; Kenchappa, Divya; Bracero, Yadriel; Singh, Ajay; Espinoza, Gerardo; Geskin, Larisa J; Saenger, Yvonne M

Adeuyan, Oluwaseyi; Gordon, Emily R; Kenchappa, Divya; Bracero, Yadriel; Singh, Ajay; Espinoza, Gerardo; Geskin, Larisa J; Saenger, Yvonne M.

Afiliação

Adeuyan O; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States.
Gordon ER; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States.
Kenchappa D; Albert Einstein College of Medicine, Bronx, NY, United States.
Bracero Y; Albert Einstein College of Medicine, Bronx, NY, United States.
Singh A; Albert Einstein College of Medicine, Bronx, NY, United States.
Espinoza G; Albert Einstein College of Medicine, Bronx, NY, United States.
Geskin LJ; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, United States.
Saenger YM; Albert Einstein College of Medicine, Bronx, NY, United States.

Front Cell Dev Biol ; 11: 1290696, 2023.

Article em En | MEDLINE | ID: mdl-37900283

Palavras-chave

checkpoint inhibition; immunotherapy; melanoma; predictive biomarker; prognostic biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google